In-house ELISA method to analyze anti-trypanosoma cruzi IgG reactivity for differential diagnosis and evaluation of Chagas disease morbidity;Método de ELISA in-house na análise da reatividade de igg anti-trypanosoma cruzi para o diagnóstico diferencial e avaliação da morbidade da doença de Chagas

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 45, Issue 1, 2012, Pages 35-44

  Santos, Lilian da Silva ^a   Torres, Rosália Morais ^b   Machado de Assis, Girley Francisco ^a   Bahia, Maria Terezinha ^a   Martins, Helen Rodrigues ^a,c   Teixeira Carvalho, Andréa ^d   Coelho dos Reis, Jordana Grazziela Alves ^e   Albajar Viñas, Pedro ^d   Martins Filho, Olindo Assis ^d   de Lana, Marta ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSIDADE FEDERAL DOS VALES DO JEQUITINHONHA E MUCURI   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Chagas disease morbidity; Differential diagnosis; IgG subclasses; In house ELISA

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ANTIGEN ANTIBODY REACTION; ARTICLE; BRAZIL; CHAGAS DISEASE; CONTROLLED STUDY; CROSS REACTION; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PARASITE SERODIAGNOSIS; PATIENT MONITORING; SENSITIVITY AND SPECIFICITY; SKIN LEISHMANIASIS; SYPHILIS; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIGEN-ANTIBODY REACTIONS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA CRUZI; YOUNG ADULT;

HEPATITIS C VIRUS; TRYPANOSOMA CRUZI;

EID: 84857979423     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0037-86822012000100008     Document Type: Article

References (27)

1. Pan American Health Organization. Estimación cuantitativa de la enfermedad de Chagas en las Américas. Montevideo, Uruguay: OPS/HDM/CD/425-06; 2006. p. 1-28.
2. Schmunis GA. Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Mem Inst Oswaldo Cruz 2007; 102 (suppl 1):75-85.
3. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001; 1:92-100.
4. Bern C, Coura JC, Goldenberg S, Guhl F, Junqueira ACV, Lorca M, et al. International meeting: new diagnostic tests are urgently needed to treat patients with Chagas disease. Médecins Sans Frontières. Campaign for Access to Essential Medicines. Technical Report. Rev Soc Bras Med Trop 2008; 41:315-319.
5. Zarate-Blades CR, Bladés N, Nascimento MS, Silveira JF, Umezawa ES. Diagnostic performance of tests based on Trypanosoma cruzi excreted-secreted antigens in an endemic area for Chagas'disease in Bolivia. Diagn Microbiol Infect Dis 2006; 57:229-232.
6. Gomes YM, Pereira VRA, Nakazawa M, Rosa DS, Barros MNDS, Ferreira AGP, et al. Serodiagnosis of chronic Chagas infection by using EIERecombinant- Chagas-Biomanguinhos kit. Mem Inst Oswaldo Cruz 2001; 96:497-501.
7. Cerban FM, Gea S, Menso E, Vottero-Cima E. Chagas' disease: IgG isotypes against Trypanosoma cruzi cytosol acidic antigens in patients with different degrees of heart damage. Clin Immunol Immunopathol 1993; 67:25-30.
8. Cordeiro FD, Martins-Filho OA, Rocha MOC, Adad SJ, Corrêa-Oliveira R, Romanha AJ. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of humam Chagas' disease. Clin Diagn Lab Immunol 2001; 1:112-118.
9. Hernandez-Becerril N, Nava A, Reyes PA, Monteon VM. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients. Arch Cardiol Mex 2001; 71:199-205.
10. Morgan J, Dias JCP, Gontijo ED, Bahia-Oliveira L, Correa-Oliveira R, Colley DG, et al. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg 1996; 55:355-359.
11. Morgan J, Colley DG, Pinto Dias JC, Gontijo ED, Bahia-Oliveira L, Correa-Oliveira R, et al. Analyses of anti-Trypanosoma cruzi antibody isotype specificities by western blot in sera from patients with different forms of Chagas'disease. J Parasitol 1998; 84:641-643.
12. Verçosa AFA, Lorena VMB, Carvalho CL, Melo MFAD, Cavalcanti MGA, Silva ED, et al. Chagas'disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients. J Clin Lab Anal 2007; 21:271-276.
13. Solana ME, Katzin AM, Umezawa ES, Miatello CS. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas'disease. J Clin Microbiol 1995; 33:1456-1460.
14. Primavera KSC, Umezawa ES, Peres BA, Camargo ME, Hoshino-Shimizu S. Chagas'disease: IgA, IgM, and IgG antibodies to T. cruzi amastigote, trypomastigote and epimastigote antigens in acute and in different chronic forms of the disease. Rev Inst Med Trop São Paulo 1990; 32:172-180.
15. Primavera KSC, Hoshino-Shimizu S, Umezawa ES, Peres BA, Manigot DA, Camargo ME. Immunoglobulin A antibodies to Trypanosoma cruzi antigens in digestive forms of Chagas'disease. J Clin Microbiol 1988; 26:2101-2104.
16. Rezende JM, Moreira H. Chagasic megaesophagus and megacolon. Historical review and present concepts. Arq Gastroenterol 1988; 25 (special issue):32-43.
17. Ministério da Saúde. Brazilian Consensus on Chagas Disease. Rev Soc Bras Med Trop 2005; 38 (supl 3):7-29.
18. Voller A, Bidwell DE, Bartlett A. Enzyme immunoassays in diagnostic medicine. Theory and pratice. Bull World Health Organ 1976; 53:55-65.
19. Greiner M, Sohr D, Göbel P. A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests. J Immunol Methods 1995; 185:123-132.
20. Rocha RDR, Gontijo CMF, Elói-Santos S, Carvalho AT, Corrêa-Oliveira R, Marques MJ, et al. Anti-live Leishmania (Viannia) braziliensis, promastigote antibodies, detected by flow cytometry to identify active infection in American cutaneous leishmaniasis. Rev Soc Bras Med Trop 2002; 35:551-562.
21. Araújo FG. Analysis of Trypanosoma cruzi antigens bound by specific antibodies and by antibodies to related Trypanosomatids. Infect Immun 1986; 53:179-185.
22. Chiller TM, Samudio MA, Zoulek G. IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas'disease and leishmaniasis. Am J Trop Med Hyg 1990; 43:650-656.
23. Lemos EM, Gomes IT, Carvalho SFG, Rocha RDR, Pissinate JF, Martins-Filho OA, et al. Detection of anti-Leishmania (Leishmania) chagasi immunoglobulin G by flow cytometry for cure assessment following chemotherapeutic treatment of american visceral leishmaniasis. Clin Vaccine Immunol 2007; 14:569-576.
24. Gusmão R, Rezende JM, Rassi A, Gam AA, Neva FA. Antibody levels to Trypanosoma cruzi in infected patients with and without evidence of chronic Chagas'disease. Am J Trop Med Hyg 1982; 31:452-458.
25. Zauza PL, Borges-Pereira J. Sera levels of IgG anti-Trypanosoma cruzi on evolution of the chronic chagasic cardiopathy in interval of 10 years. Rev Soc Bras Med Trop 2001; 34:399-405.
26. Michailowisky V, Luhrs K, Rocha MOC, Fouts D, Gazzinelli RT, Manning JE. Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas disease. Infect Immun 2003; 71:3165-3171.
27. Motran CC, Serra HM, Gea SE, Vullo CM, Vottero-Cima E. Antibody isotypes profiles against Trypanosoma cruzi acidic antigens in two Amerindian populations from a Chagas'disease endemic area. Acta Trop 1994; 58:105-114.